Botox maker Allergan Inc, fighting a hostile takeover bid by Valeant Pharmaceuticals Inc, said on Monday it was approached about a potential transaction by another party, identified as Actavis Plc by a source familiar with the situation. Valeant and Pershing Square Capital Management, which owns nearly a 10 percent stake in Allergan, made an offer that is now worth $55 billion for Allergan.